Health
Parkinson’s risk increases with exposure to common chemical, study suggests
NEWYou can now listen to Fox News articles!
A pesticide commonly used in America’s food supply has been linked to Parkinson’s disease, new research suggests.
A UCLA study published in the journal Springer Nature Link suggests that exposure to chlorpyrifos could increase the risk of the neurological disease.
The chemical is often used on agricultural products like soybeans, fruit and nut trees, broccoli, cauliflower and other row crops, according to the U.S. Environmental Protection Agency.
EARLY PARKINSON’S COULD BE DETECTED DECADES BEFORE SYMPTOMS WITH SIMPLE BLOOD TEST
The study compared 829 people with Parkinson’s to 824 people without the disease over a 45-year period, focusing on their proximity to chlorpyrifos.
The researchers also conducted mouse experiments, where mice inhaled the pesticide as humans would for 11 weeks. Experiments were also carried out on zebrafish to study cell-level brain damage.
Chlorpyrifos is often used on agricultural products like soybeans, fruit and nut trees, broccoli, cauliflower and other row crops, according to the U.S. Environmental Protection Agency. (iStock)
In humans, the study revealed that long-term exposure to chlorpyrifos led to more than a 2.5 times higher risk of Parkinson’s.
In mice, exposure to the pesticide caused movement problems similar to Parkinson’s symptoms, loss of dopamine-producing neurons, increased brain inflammation and build-up of harmful proteins.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Zebrafish suffered brain cell death and damage linked to failure in the cell’s “cleanup system,” according to the study press release.
Dr. Jeff Bronstein, director of the Movement Disorders Program at UCLA and professor of neurology and molecular toxicology, noted that previous human studies also suggested an association between chlorpyrifos exposure and Parkinson’s.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“[We were] surprised that the mechanism of toxicity was apparent in both mice and zebrafish,” he said. “We rarely find such consistent results in different animal models.”
A researcher commented that the consistency in results between human and animal subjects is “rare.” (iStock)
The researcher emphasized that the association between pesticide exposure and Parkinson’s was “very strong,” and the longer someone was exposed, the higher the risk became.
“People should avoid exposure to CPF and similar pesticides (organophosphates) by not using them in their home, eating organics, and washing fruits and vegetables before eating them,” Bronstein advised.
Study limitations
The study did have some limitations, the researchers acknowledged, primarily that it was observational, meaning it shows an association but cannot prove causation.
CLICK HERE FOR MORE HEALTH STORIES
It also estimated exposure based on participants’ locations, and did not measure diet, indoor exposure or personal lifestyle behaviors. Additionally, the results of the animal models can’t be translated directly to humans.
There was also the possibility that chlorpyrifos was used along with other chemicals, which means it could be difficult to measure its specific impact, the study noted.
Chlorpyrifos is used to control different kinds of pests, like termites, mosquitoes and roundworms, among crops. (iStock)
Industry reaction
Chlorpyrifos is used to control different kinds of pests, like termites, mosquitoes and roundworms, among crops, according to the National Pesticide Information Center (NPIC) at Oregon State University.
People can be exposed to the pesticide by breathing it in or by consuming contaminated food or water.
In 2021, the EPA banned the use of chlorpyrifos on food crops, but a federal appeals court overturned that decision in 2023, allowing its use to resume on some crops while regulators revisit the rule.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
In January 2026, the EPA issued an update outlining plans to move forward with a rule that would ban most uses of chlorpyrifos.
“Chlorpyrifos is subject to registration review, a process required under FIFRA (the Federal Insecticide, Fungicide, and Rodenticide Act) in which registered pesticides are comprehensively evaluated every 15 years against current safety standards and the latest scientific evidence,” the EPA said in a statement sent to Fox News Digital.
“EPA is currently developing a revised human health risk assessment for chlorpyrifos as part of that review, and will consider this study alongside any other relevant submissions,” the agency said in a statement sent to Fox News Digital. (Getty)
“EPA is currently developing a revised human health risk assessment for chlorpyrifos as part of that review, and will consider this study alongside any other relevant submissions. Where the science calls for stronger protections or tolerance revocations, EPA will act without hesitation and without delay.”
Fox News Digital reached out to several manufacturers of the chemical for comment.
“People should avoid exposure to CPF and similar pesticides.”
Corteva, an Indiana agrichemical company formed in 2019 through the merger of Dow Chemical and DuPont, announced in 2020 that it would end production of chlorpyrifos within the year, citing declining sales.
In April 2022, the German chemical company BASF requested the cancellation of its pesticide registrations for products containing chlorpyrifos.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“BASF does not manufacture chlorpyrifos and does not have any pesticide registrations issued by the U.S. EPA for chlorpyrifos-containing products,” the company told Fox News Digital.
No products from Corteva or BASF were included in the study linking chlorpyrifos to Parkinson’s disease.
Health
Measles-infected traveler may have exposed passengers at LAX and nearby hotel, health officials warn
NEWYou can now listen to Fox News articles!
A traveler infected with measles may have exposed passengers at Los Angeles International Airport and guests at a nearby hotel after arriving in Los Angeles County earlier this month, health officials said Wednesday.
The Los Angeles County Department of Public Health said it is investigating a confirmed measles case involving a traveler who arrived aboard Cathay Pacific Flight CX 884 on June 11. The traveler was infectious while passing through Los Angeles County, potentially exposing others at LAX and the Hilton Los Angeles Airport Hotel.
The case marks the sixth measles infection reported in Los Angeles County this year. Health officials said the risk of exposure could increase as summer travel ramps up and Los Angeles welcomes international visitors for FIFA World Cup events being held in the region.
MEASLES CASES CONFIRMED AT FOUR MAJOR US AIRPORTS ACROSS COUNTRY AMID PEAK HOLIDAY TRAVEL
A 3D illustration shows measles virus particles. (iStock)
According to health officials, anyone who was at the Tom Bradley International Terminal between 10 a.m. and noon on June 11 may have been exposed. Officials also identified a potential exposure at the Hilton Los Angeles Airport Hotel, located at 5711 W. Century Blvd., between 11:15 a.m. and 12:15 p.m. that same day.
The Centers for Disease Control and Prevention is working with local health departments to notify passengers who were seated near the infected traveler on the international flight.
People who were at either location during the listed times could develop symptoms between seven and 21 days after exposure, officials said. The last day to monitor for symptoms is July 2.
AT LEAST 46 CHILDREN DEAD AMID MEASLES OUTBREAK AS VIRUS SPREADS GLOBALLY
Los Angeles International Airport is seen in Los Angeles, California. Health officials said a traveler infected with measles may have exposed passengers at LAX on June 11. (Michael Yanow/NurPhoto)
“As measles cases increase, it is important that residents take steps to make sure they are fully protected,” Los Angeles County Health Officer Dr. Muntu Davis said. “The MMR vaccine is the safest and most reliable way to prevent measles and protect yourself, your family, and your community.”
Travelers exit a terminal at Los Angeles International Airport in Los Angeles on Monday, March 23, 2026. (Ethan Swope/AP Photo)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Symptoms include fever, cough, runny nose, red and watery eyes, followed by a rash that typically begins on the face before spreading to the rest of the body.
Fox News Digital reached out to the Los Angeles County Department of Public Health for additional comment but did not receive a response.
new video loaded: Wii Bowling Takes Over Tulsa Retirement Homes
transcript
transcript
Wii Bowling Takes Over Tulsa Retirement Homes
Retirement communities in Tulsa, Okla., compete against one another in a Nintendo Wii Sports bowling league.
-
“That’s how you win.” “There you go, Ron.” “Way to go.”
By Nick Oxford, Alisa Shodiyev Kaff and Alexandra E. Petri
June 19, 2026
NEWYou can now listen to Fox News articles!
As the popularity of GLP-1 drugs continues to climb, significant weight loss associated with the medications has been linked to a growing list of cosmetic concerns.
Some surgeons report that more patients are seeking treatments for so-called “Ozempic earlobes,” which reportedly appear thinner, longer or more sagging after the loss of facial fat.
“The use of semaglutides causes you to lose fat across your body, including the small, fat pads of the earlobes,” facial plastic surgeon Sachin S. Parikh, MD, told NewBeauty.
OZEMPIC, OTHER SEMAGLUTIDES LINKED TO HAIR LOSS: HERE’S WHAT TO KNOW
“It’s important to note that semaglutides do not damage ear tissue or affect hearing in any way, so any intervention would be purely cosmetic,” added the California-based doctor.
Some of the potential treatments for “Ozempic earlobes” may include dermal filler, fat transfer, laser treatments or surgical earlobe reduction, according to the report.
As the popularity of GLP-1 drugs continues to climb, significant weight loss associated with the medications has been linked to a growing list of cosmetic concerns. (iStock)
Dr. Mohammed Asif from Duly Health and Care in Naperville, Illinois, said that while he hasn’t personally noticed an uptick in ear surgeries, he has seen a rise in other procedures due to GLP-1-triggered weight loss.
Some of those include panniculectomies (Ozempic skin removal surgery) and abdominoplasties (tummy tucks).
PLASTIC SURGERY TRENDS TAKE A SURPRISING TURN, AS DOCTORS SEE MORE PATIENTS ‘SIZING DOWN’
“There has been a significant increase in body contouring procedures among patients with GLP-1 weight loss,” Asif told Fox News Digital.
“In my practice, I’ve seen a significant surge in breast lifts, panniculectomies (skin removal surgery), abdominoplasties (tummy tucks), brachioplasties (arm lifts) and thighplasties due to weight loss.”
TOP COSMETIC PROCEDURES REVEALED IN NEW REPORT: WHAT’S TRENDING AND WHY
Healing and recovery are “far greater and less complicated” than with bariatric surgery weight loss, Asif noted.
“This is due to the gradual weight loss achieved over time with GLP-1s.”
“Ozempic breast” is another common complaint, according to Dr. Michael Omidi, a double board-certified plastic surgeon practicing in Beverly Hills.
“There has been a significant increase in body contouring procedures among patients with GLP-1 weight loss,” a doctor told Fox News Digital. (iStock)
“Women in their 30s and 40s would not typically need a breast lift, but when you’re taking drugs like Ozempic or Wegovy that cause rapid weight loss, women can see gravity take its toll on their breasts,” he told Fox News Digital.
“When women, especially younger ones, lose fat too fast, it causes the breasts, which are comprised of fat, glandular tissue and skin, to lose volume,” he went on. “The skin and supporting ligaments don’t always bouce back at the same rate as the weight loss, resulting in breasts that can appear saggy and deflated.”
NEW OBESITY TREATMENT MAY HELP PRESERVE MUSCLE DURING WEIGHT LOSS
Dr. Samuel Golpanian, a double board-certified plastic surgeon in Beverly Hills, said he has seen “dozens” of patients – men and women alike – seeking treatments for so-called “Ozempic butt” after significant weight loss.
“This is an unintended consequence of taking GLP-1s,” he told Fox News Digital.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“Such dramatic weight loss in a short period of time causes the skin not to tighten quickly enough to keep up with the body’s changes. Our buttocks have a large amount of fat, so when that volume disappears quickly, you’ll develop a flatter, saggier behind.”
“Such dramatic weight loss in a short period of time causes the skin not to tighten quickly enough to keep up with the body’s changes,” a surgeon said. (iStock)
Kristy Hamilton, MD, a Houston-based surgeon who is a member of the American Society of Plastic Surgeons (ASPS), agreed that a growing number of patients are seeking skin-tightening procedures after losing large amounts of weight with GLP-1s.
“We’re absolutely seeing more of those patients, and I expect that trend to continue,” said Hamilton in an ASPS report.
CLICK HERE FOR MORE HEALTH STORIES
“People are losing as much as 100 pounds on this medication – and when you’re losing that amount, that’s significant. You’re certainly going to have excess skin afterward.”
The ASPS lists the following body-contouring procedures as the ones most frequently performed after substantial weight loss.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
- Tummy tuck (abdominoplasty): Removes excess abdominal skin and fat
- Lower body lift (belt lipectomy): Addresses the abdomen, buttocks, hips and thighs
- Arm lift (brachioplasty): Removes hanging upper-arm skin
- Thigh lift: Tightens excess skin of the inner thighs
- Breast lift (mastopexy): Addresses sagging, deflated breasts after weight loss
- Facelift/neck lift: Addresses facial volume loss and skin laxity after major weight loss
“People are losing as much as 100 pounds on this medication – and when you’re losing that amount, that’s significant. You’re certainly going to have excess skin afterward.” (iStock)
Experts say adequate protein intake and resistance training can help minimize the loss of lean muscle mass that often accompanies rapid weight loss, which could reduce some of the cosmetic concerns.
Golpanian also emphasized the importance of eating enough protein.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“It can be harder since your appetite is suppressed, but it’s so important to consume at least 110 grams of protein a day while taking a GLP-1 drug,” he advised.
“Also, I say this to my patients all the time: You have to lift weights to keep your muscles from atrophying. Strength training can help build muscles and preserve your glutes.”
-
Alaska25 seconds agoPilot dies in small plane crash southeast of Cordova
-
Arizona3 minutes agoArizona’s Rugged Wilderness Area Has Gorgeous Mountain Trails And Scenic Camping Spots – Islands
-
Arkansas8 minutes agoTulsa downs Northwest Arkansas | Northwest Arkansas Democrat-Gazette
-
California15 minutes agoCalifornia man arrested for alleged lewd acts, exploitation involving juveniles
-
Colorado18 minutes agoColorado neighbors lament likely closure of Roxborough library; $22 million regional library breaks ground nearby
-
Connecticut23 minutes agoDiesel fuel spill shuts two lanes on I-91 north in Wethersfield
-
Delaware30 minutes agoDelaware history in News Journal archives June 21-27: Sussex flood
-
Florida33 minutes ago7 of our favorite Florida restaurants in Vero Beach and Fellsmere
